Erlotinib Tablet is a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib Tablet works by blocking the EGFR protein, which helps cancer cells grow and multiply, thereby slowing disease progression.
With its precision-based action, it offers an effective option for selected patients under specialist supervision.
